<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB03766</drugbank-id>
  <drugbank-id>EXPT02641</drugbank-id>
  <name>Propanoic acid</name>
  <description>Sodium propionate is the sodium salt of propionic acid that exists as colorless, transparent crystals or a granular crystalline powder. It is considered generally recognized as safe (GRAS) food ingredient by FDA, where it acts as an antimicrobial agent for food preservation and flavoring agent. Its use as a food additive is also approved in Europe. Sodium propionate is is prepared by neutralizing propionic acid with sodium hydroxide. Sodium propionate was previously approved in Canada as an active ingredient in Amino-Cerv (used to treat inflammation or injury of the cervix).</description>
  <cas-number>79-09-4</cas-number>
  <unii>JHU490RVYR</unii>
  <average-mass>74.0785</average-mass>
  <monoisotopic-mass>74.036779436</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32973</ref-id>
        <pubmed-id>10469915</pubmed-id>
        <citation>Ilic L, Gowrishankar TR, Vaughan TE, Herndon TO, Weaver JC: Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits. J Control Release. 1999 Aug 27;61(1-2):185-202.</citation>
      </article>
      <article>
        <ref-id>A32977</ref-id>
        <pubmed-id>15265042</pubmed-id>
        <citation>Brock M, Buckel W: On the mechanism of action of the antifungal agent propionate. Eur J Biochem. 2004 Aug;271(15):3227-41. doi: 10.1111/j.1432-1033.2004.04255.x.</citation>
      </article>
    </articles>
    <textbooks>
      <textbook>
        <ref-id>T193</ref-id>
        <isbn>978-0071429450</isbn>
        <citation>Leonard G. Gomella, Steven A. Haist, Steven Haist (2003). Clinician's Pocket Drug Reference 2004 (3rd ed.). McGraw-Hill/Appleton &amp; Lange.</citation>
      </textbook>
    </textbooks>
    <links>
      <link>
        <ref-id>L2710</ref-id>
        <title>RXmed.com: AMINO-CERV Monograph</title>
        <url>https://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/cps-_monographs/CPS-_(General_Monographs-_A)/AMINO.html</url>
      </link>
      <link>
        <ref-id>L2715</ref-id>
        <title>FDA Listing of Propionic Acid</title>
        <url>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1081</url>
      </link>
      <link>
        <ref-id>L2716</ref-id>
        <title>EFSA Journal: Safety of the extension of use of sodium propionate (E 281) as a food additive</title>
        <url>https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2016.4546</url>
      </link>
      <link>
        <ref-id>L2722</ref-id>
        <title>INCHEM Propionic Acid and its Calcium, Potassium, and Sodium Salts (WHO Food Additive Series 5)</title>
        <url>http://www.inchem.org/documents/jecfa/jecmono/v05je16.htm</url>
      </link>
      <link>
        <ref-id>L2724</ref-id>
        <title>PROPIONIC ACID IS AN ALTERNATIVE TO ANTIBIOTICS IN POULTRY DIET</title>
        <url>https://pdfs.semanticscholar.org/0f06/ef56b8d936245c4c0d4e124f0c4dc3c6bfda.pdf</url>
      </link>
      <link>
        <ref-id>L2725</ref-id>
        <title>PubChem Propionic Acid Profile</title>
        <url>https://pubchem.ncbi.nlm.nih.gov/compound/propionic_acid#section=Pharmacology-and-Biochemistry</url>
      </link>
      <link>
        <ref-id>L2728</ref-id>
        <title>NIH Toxnet: Propionic Acid Profile</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1192</url>
      </link>
    </links>
    <attachments>
      <attachment>
        <ref-id>F50</ref-id>
        <title>Compendium of Pharmaceutical Excipients for Vaginal Formulations</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/050/original/article-5133.pdf?1525799351</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference>James R. Hazen, "Process for production of 3-(hydroxyphenylphosphinyl)-propanoic acid." U.S. Patent US4769182, issued March, 1978.</synthesis-reference>
  <indication>Propanoic acid and various direct sodium or calcium salt formulations of the acid are currently most commonly approved and indicated by organizations like the FDA and EMA for use as an antibacterial food additive preservative in animal feed and food for human consumption [L2715, L2716].&#13;
&#13;
Similarly, although the use of propanoic acid or any of its direct sodium or calcium salt formulations as excipient ingredients in pharmaceuticals is not necessarily a major role for the compound today, sodium propionate was used in some vaginal cream preparations indicated for cervicitis, cervical tears, and/or postcauterization, postcryosurgery, and postconization of the cervix [T193]. In such products, the sodium propionate was primarily used to elicit a preservative, bacteriostatic [L2710, F50] effect while other active ingredients combined in the formulation like urea, benzalkonium chloride, inositol, and methionine and cystine amino acids facilitated debridement, enhanced medication spread, epithelialization promotion, and wound healing, respectively [L2710, A32973].&#13;
&#13;
Nevertheless, a great variety of propionic acid derivatives exist as separate pharmaceuticals, each with their own unique therapeutic categories, pharmacodynamics, and pharmacokinetics.</indication>
  <pharmacodynamics>As a naturally occurring carboxylic acid, propionic acid typically undergoes metabolism via conversion to propionyl coenzyme A (propionyl-CoA), which is part of the usual metabolic pathway that carboxylic acids participate within in the human body [A32977, L2722]. Most of propionic acid's antibacterial and preservative activities subsequently stem from this metabolic pathway as the metabolic fate of propionates varies in different microorganisms, resulting in antimicrobial mechanisms of action that may revolve around differing propionate metabolites causing competition, inhibition, and/or interference effects along other metabolic pathways in the various microorganisms affected [L2722].&#13;
&#13;
In the human body, however, propionic acid is generally metabolized with little ill effect and ultimately becomes a chemical intermediate in the citric acid cycle [L2722].</pharmacodynamics>
  <mechanism-of-action>The metabolic fate of propionates varies in different microorganisms [L2722]. Some have enzyme systems that can convert succinate to propionyl-coenzyme A and through various further steps to propionate, CO2, or propionyl phoshpate [L2722]. Still others can convert propionic acid to B-alanine or directly to CO2 [L2722]. Whatever the case, the inhibiting effect for microbials is likely related to competition with acetate in the acetokinase system, to the blockage of pyruvate conversion to acetyl-coenzyme A and to interference with B-alanine in pantothenic acid syntheses [L2722].&#13;
&#13;
Moreover, other studies suggest the antimicrobial activity of propionic acid revolves around its ability to reduce the pH of its immediate environment to levels of acidity that are harmful to pathogenic microbes as well as its ability to dissociate such that its lipid soluble undissociated form is capable of entering microbial cells [L2724]. Additionally, there are also studies that suggest that propionic acid's antifungal activity may be the result of propionyl-CoA inhibiting glucose metabolism in certain species of fungus via the accumulation of the CoA-derivative [A32977].</mechanism-of-action>
  <toxicity>As a compound that is typically found naturally in the body, little to no adverse cumulative health effects have been associated with exposure to propionic acid [L2728]. Medical reports of acute exposures of workers to propionic acid show mild to moderate skin burns, mild eye redness, and one case of a mild cough and asthmatic response [L2728].</toxicity>
  <metabolism>Propionic acid is first converted to propionyl coenzyme A (propionyl-CoA), however, it directly enter either beta oxidation or the citric acid cycles [L2722]. As propionic acid has three carbons, propionyl-CoA [L2722]. In the majority of vertebrates, propionyl-CoA is carboxylated to D-methylmalonyl-CoA, which is then isomerised to L-methylmalonyl-CoA [L2722]. A vitamin B12-dependent enzyme catalyzes rearrangement of L-methylmalonyl-CoA to succinyl-CoA, which can then be used as a substrate in the citric acid cycle [L2722].</metabolism>
  <absorption>Some propionic acid is oxidized to lactic acid during absorption, but most passes to the liver, which removes nearly all of it from the portal blood [L2725]. Propionic acid represents 20-25% of absorbed volatile fatty acids [L2725].&#13;
&#13;
Propionic acid is rapidly absorbed through the gastrointestinal tract [L2725].</absorption>
  <half-life>The half-life of iv sodium propionate administered in the sheep animal model is about 6.9 +/- 0.4 minutes [L2725].</half-life>
  <protein-binding>Readily accessible data regarding the protein binding of propionic acid is not available.</protein-binding>
  <route-of-elimination>Most absorbed propionic acid is passed to the liver, which removes nearly all of it from the portal blood [L2725].&#13;
&#13;
Three days after a single oral administration of labeled sodium propionate, 77% of the radioactivity was found in expired air, and 7% in urine and feces [L2725].</route-of-elimination>
  <volume-of-distribution>Three days after a single oral administration of labeled sodium propionate, 77% of the radioactivity was found in expired air, and 7% in urine and feces [L2725]. The radioactivity found in skin, liver, intestine, and adipose tissue was 3.9, 1.1, 0.9, and 0.7%, respectively [L2725].&#13;
&#13;
Readily accessible data regarding the volume of distribution of propionic acid is not available.</volume-of-distribution>
  <clearance>Readily accessible data regarding the clearance of propionic acid is not available.</clearance>
  <classification>
    <description>This compound belongs to the class of organic compounds known as carboxylic acids. These are compounds containing a carboxylic acid group with the formula -C(=O)OH.</description>
    <direct-parent>Carboxylic acids</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Carboxylic acids</subclass>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT002690</drugbank-id>
      <name>Sodium propionate</name>
      <unii>DK6Y9P42IN</unii>
      <cas-number>6700-17-0</cas-number>
      <inchikey>HOAUAOBUGFYWMK-UHFFFAOYSA-M</inchikey>
      <average-mass>114.076</average-mass>
      <monoisotopic-mass>114.02928837</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="inn">Propionic acid</synonym>
  </synonyms>
  <products>
    <product>
      <name>Amino-cerv</name>
      <labeller>Milex, A Coopersurgical Co.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00137464</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1952-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Vaginal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Amino-cerv</name>
      <ingredients>Cystine + Inositol + Propanoic acid + Racemethionine + Urea</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids, Acyclic</category>
      <mesh-id>D000144</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Fatty Acids</category>
      <mesh-id>D005227</mesh-id>
    </category>
    <category>
      <category>Fatty Acids, Volatile</category>
      <mesh-id>D005232</mesh-id>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Ophthalmologicals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Sensory Organs</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Cream</form>
      <route>Vaginal</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="S01AX10">
      <level code="S01AX">Other antiinfectives</level>
      <level code="S01A">ANTIINFECTIVES</level>
      <level code="S01">OPHTHALMOLOGICALS</level>
      <level code="S">SENSORY ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1a8s</pdb-entry>
    <pdb-entry>1adl</pdb-entry>
    <pdb-entry>1lic</pdb-entry>
    <pdb-entry>1lie</pdb-entry>
    <pdb-entry>1seg</pdb-entry>
    <pdb-entry>1tu9</pdb-entry>
    <pdb-entry>1uk6</pdb-entry>
    <pdb-entry>1uux</pdb-entry>
    <pdb-entry>1uuy</pdb-entry>
    <pdb-entry>2hub</pdb-entry>
    <pdb-entry>2sfp</pdb-entry>
    <pdb-entry>2uyp</pdb-entry>
    <pdb-entry>3cu8</pdb-entry>
    <pdb-entry>3e5p</pdb-entry>
    <pdb-entry>3kb6</pdb-entry>
    <pdb-entry>3nkx</pdb-entry>
    <pdb-entry>3oyp</pdb-entry>
    <pdb-entry>4cvb</pdb-entry>
    <pdb-entry>4cvc</pdb-entry>
    <pdb-entry>4h82</pdb-entry>
    <pdb-entry>4jfz</pdb-entry>
    <pdb-entry>4jg0</pdb-entry>
    <pdb-entry>4jg1</pdb-entry>
    <pdb-entry>4uwc</pdb-entry>
    <pdb-entry>4xh1</pdb-entry>
    <pdb-entry>4xh4</pdb-entry>
    <pdb-entry>4xh5</pdb-entry>
    <pdb-entry>4z7e</pdb-entry>
    <pdb-entry>5a7r</pdb-entry>
    <pdb-entry>5aoa</pdb-entry>
    <pdb-entry>5fag</pdb-entry>
    <pdb-entry>5gnx</pdb-entry>
    <pdb-entry>5gsm</pdb-entry>
    <pdb-entry>5ly1</pdb-entry>
    <pdb-entry>5ux2</pdb-entry>
    <pdb-entry>6b5q</pdb-entry>
    <pdb-entry>6f0o</pdb-entry>
    <pdb-entry>6fk3</pdb-entry>
    <pdb-entry>6fp6</pdb-entry>
    <pdb-entry>6hpp</pdb-entry>
    <pdb-entry>6nnw</pdb-entry>
    <pdb-entry>6ryf</pdb-entry>
    <pdb-entry>6ue2</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB03766.pdf?1525799558</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>0.31</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>0.68</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>3.52e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>0.48</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>74.0785</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>74.036779436</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCC(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C3H6O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>XBDQKXXYIPTUBI-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>37.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>17.27</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>7.24</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>4.75</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>1E+006 mg/L (at 25 °C)</value>
      <source>US EPA (1981)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>-20.7 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>141.1 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>0.33</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>4.88</value>
      <source>SERJEANT,EP &amp; DEMPSEY,B (1979)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>8742</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>30768</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>1032</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508742</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00163</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D02310</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>1005</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50082199</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>PPI</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>1062</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>1062</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Propionic_acid</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL14021</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP0000016</smpdb-id>
      <name>Propanoate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000198</smpdb-id>
      <name>Malonic Aciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000201</smpdb-id>
      <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000464</smpdb-id>
      <name>Vitamin K Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB01022</drugbank-id>
          <name>Phylloquinone</name>
        </drug>
        <drug>
          <drugbank-id>DB01822</drugbank-id>
          <name>(4R,5R)-1,2-dithiane-4,5-diol</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P15559</uniprot-id>
        <uniprot-id>Q9BQB6</uniprot-id>
        <uniprot-id>P00734</uniprot-id>
        <uniprot-id>P38435</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000502</smpdb-id>
      <name>Malonyl-CoA Decarboxylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB03766</drugbank-id>
        <name>Propanoic acid</name>
      </left-element>
      <right-element>
        <drugbank-id>DB02912</drugbank-id>
        <name>Propanoyl-CoA</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DB02912</drugbank-id>
        <name>Propanoyl-CoA</name>
      </left-element>
      <right-element>
        <drugbank-id>DB04045</drugbank-id>
        <name>Methylmalonyl-Coenzyme A</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>3</sequence>
      <left-element>
        <drugbank-id>DB04045</drugbank-id>
        <name>Methylmalonyl-Coenzyme A</name>
      </left-element>
      <right-element>
        <drugbank-id>DB03699</drugbank-id>
        <name>Succinyl-Coenzyme A</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001985</id>
      <name>Non-heme chloroperoxidase</name>
      <organism>Pseudomonas fluorescens</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O31158" source="Swiss-Prot">
        <name>Non-heme chloroperoxidase</name>
        <general-function>Chloride peroxidase activity</general-function>
        <specific-function/>
        <gene-name>cpo</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.03</theoretical-pi>
        <molecular-weight>29651.125</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="294">Pseudomonas fluorescens</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF031153</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>2623869</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O31158</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PRXC_PSEFL</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.11.1.10</synonym>
          <synonym>Chloride peroxidase</synonym>
          <synonym>Chloroperoxidase F</synonym>
          <synonym>CPO-F</synonym>
          <synonym>cpoF</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016632|Non-heme chloroperoxidase
MTTFTTRDGTQIYYKDWGSGQPIVFSHGWPLNADSWESQMIFLAAQGYRVIAHDRRGHGR
SSQPWSGNDMDTYADDLAQLIEHLDLRDAVLFGFSTGGGEVARYIGRHGTARVAKAGLIS
AVPPLMLKTEANPGGLPMEVFDGIRQASLADRSQLYKDLASGPFFGFNQPGAKSSAGMVD
WFWLQGMAAGHKNAYDCIKAFSETDFTEDLKKIDVPTLVVHGDADQVVPIEASGIASAAL
VKGSTLKIYSGAPHGLTDTHKDQLNADLLAFIKG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003932|825 bp
ATGACTACATTCACCACGCGTGACGGCACCCAGATTTATTACAAGGACTGGGGCAGCGGC
CAGCCGATTGTCTTCAGCCATGGCTGGCCGCTGAATGCCGACAGTTGGGAGTCGCAGATG
ATTTTCCTCGCCGCCCAGGGCTACCGGGTCATCGCTCACGACCGTCGCGGCCATGGCCGC
TCCAGCCAGCCGTGGTCCGGCAATGACATGGACACCTATGCCGATGACCTCGCGCAACTG
ATCGAACATCTGGATTTGCGCGATGCCGTGCTGTTCGGTTTCTCCACCGGTGGCGGCGAA
GTGGCGCGTTACATCGGCCGTCATGGCACCGCCCGCGTGGCCAAGGCCGGGCTGATTTCC
GCGGTGCCGCCGCTGATGCTCAAGACCGAAGCCAACCCAGGCGGCCTGCCGATGGAAGTG
TTCGACGGCATTCGCCAGGCCTCGCTGGCCGATCGCTCGCAACTGTACAAAGATCTCGCC
AGCGGCCCGTTTTTCGGTTTCAACCAGCCCGGCGCGAAATCGTCCGCCGGCATGGTCGAC
TGGTTCTGGCTGCAGGGCATGGCCGCCGGCCACAAAAACGCCTACGACTGCATCAAGGCG
TTCTCGGAAACCGACTTCACCGAAGACCTGAAGAAAATCGACGTGCCGACGCTGGTGGTG
CATGGCGACGCCGACCAGGTAGTGCCGATCGAAGCGTCGGGCATCGCCTCGGCAGCGCTG
GTCAAGGGTTCCACGCTGAAGATCTACTCCGGTGCTCCCCATGGCCTGACCGATACCCAT
AAAGATCAGCTCAACGCCGACCTGCTGGCGTTCATCAAGGGTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00561</identifier>
            <name>Abhydrolase_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>chloride peroxidase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002652</id>
      <name>Gephyrin</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NQX3" source="Swiss-Prot">
        <name>Gephyrin</name>
        <general-function>Molybdopterin molybdotransferase activity</general-function>
        <specific-function>Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Catalyzes two steps in the biosynthesis of the molybdenum cofactor. In the first step, molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released.</specific-function>
        <gene-name>GPHN</gene-name>
        <locus>14q23.3</locus>
        <cellular-location>Cell junction</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.09</theoretical-pi>
        <molecular-weight>79747.635</molecular-weight>
        <chromosome-location>14</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:15465</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GPHN</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF272663</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9NQX3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GEPH_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GPH</synonym>
          <synonym>KIAA1385</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0005202|Gephyrin
MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP
DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSL
NVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVH
DELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAI
AAKIPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPKVQSRCSSKENIL
RASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVY
AKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCG
ADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPS
EIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYP
TINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVF
MKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKAR
LSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYV
ELHKGEVVDVMVIGRL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021679|Gephyrin (GPHN)
ATGGCGACCGAGGGAATGATCCTTACTAACCACGACCATCAAATCCGTGTCGGAGTCCTT
ACAGTGAGTGATAGTTGCTTCAGGAATCTTGCAGAAGACCGCAGTGGGATAAATCTCAAA
GATCTCGTACAAGATCCTTCTTTGTTGGGTGGGACTATATCAGCATACAAGATAGTACCA
GATGAAATAGAAGAAATCAAGGAAACCCTGATAGATTGGTGTGATGAAAAGGAACTTAAT
TTGATATTAACAACTGGAGGAACAGGATTTGCACCACGAGATGTCACTCCAGAGGCCACA
AAAGAAGTAATAGAACGGGAAGCACCAGGGATGGCCCTGGCAATGCTGATGGGATCACTT
AATGTTACACCTCTGGGCATGCTCTCTAGGCCTGTATGTGGAATCAGAGGGAAAACGCTC
ATAATTAACCTGCCAGGTAGCAAGAAAGGATCTCAGGAATGCTTTCAATTCATACTGCCA
GCTCTACCTCATGCCATTGACCTTTTACGTGATGCCATTGTAAAAGTAAAGGAGGTGCAT
GATGAACTTGAAGATTTGCCTTCCCCACCTCCCCCTCTTTCCCCTCCTCCTACTACCAGC
CCCCATAAACAGACAGAAGACAAAGGAGTTCAATGTGAGGAAGAGGAAGAAGAGAAGAAA
GACAGTGGTGTTGCTTCAACAGAAGATAGTTCCTCATCACATATAACTGCAGCAGCCATT
GCTGCCAAGATTCCAGACTCCATCATTTCTCGTGGTGTTCAGGTGCTCCCACGAGACACA
GCCTCCCTCAGCACTACTCCTTCAGAATCGCCTCGTGCTCAGGCTACATCTCGCCTCTCT
ACAGCTTCCTGCCCAACACCAAAAGTCCAGTCCAGGTGCAGCAGCAAGGAGAACATTCTC
AGAGCCAGTCACAGTGCTGTCGATATCACCAAGGTGGCTAGAAGACATCGCATGTCTCCT
TTTCCTCTGACATCTATGGACAAAGCCTTTATCACAGTCCTGGAGATGACTCCGGTGCTT
GGGACAGAAATCATCAATTACCGAGATGGAATGGGGCGAGTCCTTGCTCAAGATGTATAT
GCAAAAGACAATTTACCCCCCTTCCCAGCATCAGTAAAAGATGGCTATGCTGTCCGAGCT
GCTGATGGCCCAGGAGATCGTTTCATCATTGGGGAATCCCAAGCTGGTGAACAGCCAACT
CAGACAGTAATGCCAGGACAAGTCATGCGGGTTACAACAGGTGCTCCAATACCCTGCGGT
GCTGATGCAGTAGTACAAGTGGAAGATACCGAACTTATCAGGGAATCAGATGATGGCACT
GAAGAACTTGAAGTGCGAATTCTGGTGCAAGCTCGGCCAGGCCAAGATATCAGACCCATC
GGCCATGACATTAAAAGAGGGGAATGTGTTTTGGCCAAAGGAACCCACATGGGCCCCTCA
GAGATTGGTCTTCTGGCAACTGTAGGTGTCACAGAGGTTGAAGTTAATAAGTTTCCAGTG
GTTGCAGTCATGTCAACAGGGAATGAGCTGCTAAATCCTGAAGATGACCTCTTACCAGGG
AAGATTCGAGACAGCAATCGTTCAACTCTTCTAGCAACAATTCAGGAACATGGTTACCCC
ACGATCAACTTGGGTATTGTAGGAGACAACCCAGATGACTTACTCAATGCCTTGAATGAG
GGTATCAGTCGTGCTGATGTCATCATCACATCAGGGGGTGTATCCATGGGGGAAAAGGAC
TATCTCAAGCAGGTGCTGGACATTGATCTTCATGCTCAGATCCATTTTGGCAGGGTTTTT
ATGAAACCAGGCTTGCCAACAACATTTGCAACTTTGGATATTGATGGTGTAAGAAAAATA
ATCTTTGCACTACCTGGGAATCCTGTATCGGCTGTGGTCACCTGCAATCTCTTTGTTGTG
CCTGCACTGAGGAAAATGCAGGGCATCTTGGATCCTCGGCCAACCATCATCAAAGCAAGG
TTATCATGTGATGTAAAACTTGATCCTCGTCCAGAATACCATCGGTGTATACTAACTTGG
CATCACCAAGAACCACTACCTTGGGCACAGAGTACAGGTAATCAAATGAGCAGCCGTCTG
ATGAGCATGCGCAGTGCCAATGGATTGTTGATGCTACCTCCAAAGACAGAACAGTACGTG
GAGCTCCACAAAGGCGAGGTGGTGGATGTCATGGTCATTGGACGGCTATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00994</identifier>
            <name>MoCF_biosynth</name>
          </pfam>
          <pfam>
            <identifier>PF03454</identifier>
            <name>MoeA_C</name>
          </pfam>
          <pfam>
            <identifier>PF03453</identifier>
            <name>MoeA_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoskeleton</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>molybdopterin adenylyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>molybdopterin molybdotransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>establishment of synaptic specificity at neuromuscular junction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine receptor clustering</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Mo-molybdopterin cofactor biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>molybdenum incorporation into molybdenum-molybdopterin complex</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>molybdopterin cofactor biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vitamin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>water-soluble vitamin metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002742</id>
      <name>2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase</name>
      <organism>Pseudomonas fluorescens</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P96965" source="TrEMBL">
        <name>2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase</name>
        <general-function>Hydrolase activity</general-function>
        <specific-function/>
        <gene-name>cumD</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.03</theoretical-pi>
        <molecular-weight>31489.385</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="294">Pseudomonas fluorescens</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D83955</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P96965</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>P96965_PSEFL</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0022031|2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase
MANLEIGKSILAAGVLTNYHDVGEGQPVILIHGSGPGVSAYANWRLTIPALSKFYRVIAP
DMVGFGFTDRPENYNYSKDSWVDHIIGIMDALEIEKAHIVGNSFGGGLAIATALRYSERV
DRMVLMGAAGTRFDVTEGLNAVWGYTPSIENMRNLLDIFAYDRSLVTDELARLRYEASIQ
PGFQESFSSMFPEPRQRWIDALASSDEDIKTLPNETLIIHGREDQVVPLSSSLRLGELID
RAQLHVFGRCGHWTQIEQTDRFNRLVVEFFNEANTPKLVGRP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0005375|849 bp
ATGGCAAACCTGGAAATAGGTAAAAGTATTTTAGCTGCAGGGGTTCTAACAAACTATCAC
GATGTCGGGGAGGGACAGCCTGTGATACTAATTCATGGTTCTGGGCCCGGCGTGAGCGCT
TATGCGAATTGGCGACTGACCATTCCTGCTCTGAGCAAGTTTTATCGTGTTATCGCCCCT
GATATGGTTGGTTTTGGCTTTACGGATCGACCTGAAAACTATAATTATTCCAAGGATAGT
TGGGTTGACCATATAATCGGTATTATGGACGCCCTGGAAATAGAAAAGGCTCACATCGTA
GGTAACTCATTCGGTGGGGGGCTGGCGATTGCTACCGCGCTTCGTTATTCGGAGCGCGTT
GATCGTATGGTTCTGATGGGGGCGGCCGGTACTCGCTTTGACGTGACAGAGGGCCTGAAC
GCGGTGTGGGGTTACACGCCGTCGATAGAAAACATGCGTAATCTCCTCGATATATTCGCT
TATGATCGCTCCTTAGTCACCGACGAATTAGCGAGACTTCGATATGAGGCGAGTATTCAG
CCAGGATTTCAAGAGTCATTCTCCAGCATGTTTCCTGAGCCGCGCCAACGCTGGATAGAC
GCGTTGGCTAGCTCGGATGAAGATATCAAGACTCTTCCCAATGAGACACTGATTATTCAT
GGTCGAGAGGATCAGGTTGTTCCTCTATCCAGCAGTCTGCGTCTAGGCGAACTTATCGAC
CGGGCGCAGTTGCATGTTTTCGGGCGATGTGGGCACTGGACACAAATTGAGCAGACTGAC
CGATTCAATCGTCTTGTGGTCGAGTTTTTTAATGAGGCCAACACACCTAAACTAGTGGGT
CGTCCGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00561</identifier>
            <name>Abhydrolase_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>hydrolase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001344</id>
      <name>Alanine racemase</name>
      <organism>Geobacillus stearothermophilus</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P10724" source="Swiss-Prot">
        <name>Alanine racemase</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function>Catalyzes the interconversion of L-alanine and D-alanine. Also weakly active on serine.</specific-function>
        <gene-name>alr</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.11</theoretical-pi>
        <molecular-weight>43592.715</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1422">Geobacillus stearothermophilus</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M19142</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>142467</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P10724</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ALR_GEOSE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>5.1.1.1</synonym>
          <synonym>dal</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010938|Alanine racemase
MNDFHRDTWAEVDLDAIYDNVENLRRLLPDDTHIMAVVKANAYGHGDVQVARTALEAGAS
RLAVAFLDEALALREKGIEAPILVLGASRPADAALAAQQRIALTVFRSDWLEEASALYSG
PFPIHFHLKMDTGMGRLGVKDEEETKRIVALIERHPHFVLEGLYTHFATADEVNTDYFSY
QYTRFLHMLEWLPSRPPLVHCANSAASLRFPDRTFNMVRFGIAMYGLAPSPGIKPLLPYP
LKEAFSLHSRLVHVKKLQPGEKVSYGATYTAQTEEWIGTIPIGYADGWLRRLQHFHVLVD
GQKAPIVGRICMDQCMIRLPGPLPVGTKVTLIGRQGDEVISIDDVARHLETINYEVPCTI
SYRVPRIFFRHKRIMEVRNAIGRGESSA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0002668|1161 bp
ATGAACGACTTTCATCGCGATACGTGGGCGGAAGTGGATTTGGACGCCATTTACGACAAT
GTGGAGAATTTGCGCCGTTTGCTGCCGGACGACACGCACATTATGGCGGTCGTGAAAGCG
AACGCCTATGGACATGGGGATGTGCAGGTGGCAAGGACAGCGCTCGAACGGGGGCCTCCG
CCTGCGGTTGCCTTTTTGGATGAGGCGCTCGCTTTAAGGGAAAAAGGAATCGAAGCGCCG
ATTCTAGTTCTCGGGGCTTCCCGTCCAGCTGATGCGGCGCTGGCCGCCCAGCAGCGCATT
GCCCTGACCGTGTTCCGCTCCGACTGGTTGGAAGAAGCGTCCGCCCTTTACAGCGGCCCT
TTTCCTATTCATTTCCATTTGAAAATGGACACCGGCATGGGACGGCTTGGAGTGAAAGAC
GAGGAAGAGACGAAACGAATCGTAGCGCTGATTGAGCGCCATCCGCATTTTGTGCTTGAA
GGGTTGTACACGCATTTTGCGACTGCGGATGAGGTGAACACCGATTATTTTTCCTATCAG
TATACCCGTTTTTTGCACATGCTCGAATGGCTGCCGTCGCGCCCGCCGCTCGTCCATTGC
GCCAACAGCGCAGCGTCGCTCCGTTTCCCTGACCGGACGTTCAATATGGTCCGCTTCGGC
ATTGCCATGTATGGGCTTGCCCCGTCGCCCGGCATCAAGCCGCTGCTGCCGTATCCATTA
AAAGAAGCATTTTCGCTCCATAGCCGCCTCGTACACGTCAAAAAACTGCAACCAGGCGAA
AAGGTGAGCTATGGTGCGACGTACACTGCGCAGACGGAGGAGTGGATCGGGACGATTCCG
ATCGGCTATGCGGACGGCGTCCGCCGCCTGCAGCACTTTCATGTCCTTGTTGACGGACAA
AAGGCGCCGATTGTCGGCCGCATTTGCATGGACCAGTGCATGATCCGCCTGCCTGGTCCG
CTGCCGGTCGGCACGAAGGTGACACTGATTGGTCGCCAAGGGGACGAGGTAATTTCCATT
GATGATGTCGCTCGCCATTTGGAAACGATCAACTACGAAGTGCCTTGCACGATCAGTTAT
CGAGTGCCCCGTATTTTTTTCCGCCATAAGCGTATAATGGAAGTGAGAAACGCCATTGGC
CGCGGGGAAAGCAGTGCATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00842</identifier>
            <name>Ala_racemase_C</name>
          </pfam>
          <pfam>
            <identifier>PF01168</identifier>
            <name>Ala_racemase_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>alanine racemase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>D-alanine biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers>
    <carrier>
      <id>BE0001194</id>
      <name>Fatty acid-binding protein, adipocyte</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15090" source="Swiss-Prot">
        <name>Fatty acid-binding protein, adipocyte</name>
        <general-function>Transporter activity</general-function>
        <specific-function>Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus (By similarity).</specific-function>
        <gene-name>FABP4</gene-name>
        <locus>8q21</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.25</theoretical-pi>
        <molecular-weight>14718.815</molecular-weight>
        <chromosome-location>8</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:3559</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>FABP4</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>J02874</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>178347</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>2534</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P15090</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FABP4_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>A-FABP</synonym>
          <synonym>Adipocyte lipid-binding protein</synonym>
          <synonym>Adipocyte-type fatty acid-binding protein</synonym>
          <synonym>AFABP</synonym>
          <synonym>ALBP</synonym>
          <synonym>Fatty acid-binding protein 4</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016343|Fatty acid-binding protein, adipocyte
MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN
TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM
KGVTSTRVYERA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016344|Fatty acid-binding protein, adipocyte (FABP4)
ATGTGTGATGCTTTTGTAGGTACCTGGAAACTTGTCTCCAGTGAAAACTTTGATGATTAT
ATGAAAGAAGTAGGAGTGGGCTTTGCCACCAGGAAAGTGGCTGGCATGGCCAAACCTAAC
ATGATCATCAGTGTGAATGGGGATGTGATCACCATTAAATCTGAAAGTACCTTTAAAAAT
ACTGAGATTTCCTTCATACTGGGCCAGGAATTTGACGAAGTCACTGCAGATGACAGGAAA
GTCAAGAGCACCATAACCTTAGATGGGGGTGTCCTGGTACATGTGCAGAAATGGGATGGA
AAATCAACCACCATAAAGAGAAAACGAGAGGATGATAAACTGGTGGTGGAATGCGTCATG
AAAGGCGTCACTTCCACGAGAGTTTATGAGAGAGCATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00061</identifier>
            <name>Lipocalin</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>lipid particle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>fatty acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>brown fat cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to lithium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cholesterol homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cytokine production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of inflammatory response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>triglyceride catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>white fat cell differentiation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </carrier>
  </carriers>
  <transporters/>
</drug>